Street Calls of the Week
Progress Software Corporation’s stock reached a 52-week low, hitting $41.11, representing a 42% decline from its peak of $70.56. According to InvestingPro analysis, the company maintains impressive gross profit margins of 86% despite the challenging market environment. Over the past year, the stock has experienced a significant decline, with a 1-year change of -27.72%. This downturn reflects broader industry trends and company-specific challenges that have impacted investor confidence. As Progress Software navigates these conditions, market observers will be watching closely for signs of recovery or further declines, particularly with earnings due in 6 days. InvestingPro analysis suggests the stock is currently undervalued, with analyst targets ranging from $57 to $83 per share. Discover more insights and 8 additional ProTips with an InvestingPro subscription.
In other recent news, Progress Software Corporation has announced the release of Flowmon ADS 12.5, an updated version of its network anomaly detection system with new AI-driven capabilities. This release includes AI-powered threat briefings and enhanced visualization tools to improve threat detection and response processes. Additionally, Progress Software has expanded its AI-powered developer capabilities in the Q3 2025 release of its Telerik and Kendo UI toolsets, extending AI Coding Assistants across all major UI component libraries.
In financial developments, Progress Software has increased its revolving credit facility to $1.5 billion, up from $900 million, with a new maturity date set for July 31, 2030. Analyst activity around the company has seen Citi lower its price target to $57, citing softer-than-expected cash flow and other financial concerns. Conversely, DA Davidson has raised its price target to $75, maintaining a Buy rating based on the company’s consistent business strength in its latest quarterly report. These updates reflect a mix of strategic product enhancements and varied analyst perspectives on the company’s financial health.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.